News & Updates

Show Multimedia Only
Fewer CV events after COVID-19 vaccine-related myocarditis

Fewer CV events after COVID-19 vaccine-related myocarditis

13 Sep 2024 byElvira Manzano

In a nationwide French cohort study, myocarditis attributed to COVID-19 mRNA vaccination causes fewer cardiovascular (CV) events at 18 months of follow-up than that attributed to SARS-CoV-2 infection or myocarditis of conventional aetiologies.

13 Sep 2024
Hydroxychloroquine protects SLE patients against CV events

Hydroxychloroquine protects SLE patients against CV events

11 Sep 2024

Among patients with systemic lupus erythematosus (SLE), those who use of hydroxychloroquine are less likely to experience cardiovascular events, as reported in a study.

11 Sep 2024
Four-drug pill beats three separate meds in difficult-to-treat hypertension

Four-drug pill beats three separate meds in difficult-to-treat hypertension

07 Sep 2024 byJairia Dela Cruz

For individuals with difficult-to-treat hypertension who are struggling with three separate medications, a single pill that combines four blood pressure (BP)-lowering drugs may help with BP control, as shown in the phase III QUADRO trial.

07 Sep 2024